Literature DB >> 33569018

Gambling in COVID-19 Lockdown in the UK: Depression, Stress, and Anxiety.

Steve Sharman1,2, Amanda Roberts3, Henrietta Bowden-Jones4,5,6, John Strang1.   

Abstract

To combat the spread of COVID-19, the UK Government implemented a range of "lockdown" measures. Lockdown has necessarily changed the gambling habits of gamblers in the UK, and the impact of these measures on the mental health of gamblers is unknown. To understand the impact of lockdown on gamblers, in April 2020, after ~6 weeks of lockdown, participants (N = 1,028, 72% female) completed an online questionnaire. Gambling engagement data was collected for pre-lockdown via the Brief Problem Gambling Screen (BPGS) allowing participants to be classified as Non-Gamblers (NG), Non-Problem Gamblers (NPG) or Potential Problem Gamblers (PPG). The Depression, Stress, and Anxiety Scale (DASS21) was used to measure depression, stress, and anxiety scores both pre- and during-lockdown. Results indicate that depression, stress and anxiety has increased across the whole sample. Participants classified in the PPG group reported higher scores on each sub scale at both baseline and during lockdown. Increases were observed on each DASS21 subscale, for each gambler group, however despite variable significance and effect sizes, the magnitude of increases did not differ between groups. Lockdown has had a significant impact on mental health of participants; whilst depression stress and anxiety remain highest in potential problem gamblers, pre-lockdown gambler status did not affect changes in DASS21 scores.
Copyright © 2021 Sharman, Roberts, Bowden-Jones and Strang.

Entities:  

Keywords:  COVID-19; anxiety; depression; disordered gambling; gambling; stress

Year:  2021        PMID: 33569018      PMCID: PMC7868396          DOI: 10.3389/fpsyt.2021.621497

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  6 in total

1.  Cross-Addiction Risk Profile Associations with COVID-19 Anxiety: a Preliminary Exploratory Study.

Authors:  Brendan Dowd; Kaiden Hein; Stephanie L Diez; Maria Prokofieva; Lee Kannis-Dymand; Vasileios Stavropoulos
Journal:  Int J Ment Health Addict       Date:  2022-07-06       Impact factor: 11.555

Review 2.  The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis.

Authors:  Georgia Salanti; Natalie Peter; Thomy Tonia; Alexander Holloway; Ian R White; Leila Darwish; Nicola Low; Matthias Egger; Andreas D Haas; Seena Fazel; Ronald C Kessler; Helen Herrman; Christian Kieling; Dominique J F De Quervain; Simone N Vigod; Vikram Patel; Tianjing Li; Pim Cuijpers; Andrea Cipriani; Toshi A Furukawa; Stefan Leucht
Journal:  Ann Intern Med       Date:  2022-10-18       Impact factor: 51.598

3.  Treatment and help services for gambling during COVID-19: Experiences of gamblers and their concerned significant others.

Authors:  Virve Marionneau; Johanna Järvinen-Tassopoulos
Journal:  Nordisk Alkohol Nark       Date:  2021-08-12

4.  Gambling at the time of COVID-19: Results from interviews in an Italian sample of gamblers.

Authors:  Ilaria Cataldo; Eleonora Casonato; Ermelinda Levari; Attilio Negri; Pierluigi Simonato; Giulia Tomasi; Giovanna Branz; Aurora Coppola; Pietro Gianfranceschi; Eva Leoni; Pietro Mistretta; Martina Stefani; Miriam Vanzetta; Anna Franceschini; Gianluca Esposito; Ornella Corazza
Journal:  Emerg Trends Drugs Addict Health       Date:  2022-02-01

5.  Investigating the prevalence of anxiety and depression during the first COVID-19 lockdown in the United Kingdom: Systematic review and meta-analyses.

Authors:  Luca Marie Dettmann; Sally Adams; Gemma Taylor
Journal:  Br J Clin Psychol       Date:  2022-02-09

Review 6.  Estimation of Behavioral Addiction Prevalence During COVID-19 Pandemic: A Systematic Review and Meta-analysis.

Authors:  Zainab Alimoradi; Aida Lotfi; Chung-Ying Lin; Mark D Griffiths; Amir H Pakpour
Journal:  Curr Addict Rep       Date:  2022-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.